Molecular Pathology, Diagnostics, and Therapeutics
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to enable rapid publication of contributions on all aspects of molecular pathology, ranging from basic research at the molecular level, to clinical and forensic applications. We welcome studies on molecular mechanisms, diagnostics, and therapeutics of human disease and relevant experimental models using cellular, molecular, biological, chemical and immunological approaches. Topics include, but are not limited to:
- the molecular and cellular mechanism of diseases and injury
- immunopathology and diseases
- mechanisms of immunotoxicity
- matrix pathobiology
- in vitro and in vivo aspects of inflammation and autophagy
- mechanism of tissue alterations
- mechanisms of genotoxicity
- musculoskeletal pathology
- molecular diagnostics
- molecular targeted therapy
- cell injury, repair, aging and apoptosis
- stem cell or gene therapy
- novel mechanisms of carcinogenesis
- application of molecular pathology to tissue identification
We also welcome reviews on these subjects, particularly those that challenge existing concepts.
Keywords
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Understanding Traumatic Brain Injury: Mechanisms and Therapeutic Targets 3.0 (Deadline: 30 May 2022)
- Targeted Cancer Therapy and Mechanisms of Resistance 2.0 (Deadline: 30 May 2022)
- Neuroprotection: Rescue from Neuronal Death in the Brain 2.0 (Deadline: 30 May 2022)
- Intercellular and Intracellular Communication in Human Health and Disease 2.0 (Deadline: 30 May 2022)
- Pathogenesis and Treatment of Cutaneous Lymphoma (Deadline: 30 May 2022)
- Oxidative Stress and Skeletal Muscle Function (Deadline: 30 May 2022)
- Molecular Approaches for Understanding Dengue Disease (Deadline: 30 May 2022)
- MicroRNA Signaling in Human Diseases 2.0 (Deadline: 31 May 2022)
- Atherosclerosis: From Molecular Biology to Therapeutic Perspective 2.0 (Deadline: 31 May 2022)
- Retinal Degeneration: From Pathophysiology to Therapeutic Approaches 3.0 (Deadline: 31 May 2022)
- Molecular Mechanisms of Kidney Injury (Deadline: 31 May 2022)
- The Emerging Role of RNA in Diseases and Cancers (Deadline: 31 May 2022)
- MicroRNA in Cardiac Health and Disease (Deadline: 31 May 2022)
- The Physiology of Striated Muscle Tissues (Deadline: 31 May 2022)
- Cellular Senescence in Physiological and Pathological Processes (Deadline: 31 May 2022)
- Sirtuins and Epigenetics in Aging and Diseases 2.0 (Deadline: 31 May 2022)
- Emerging Treatment for Cardiovascular Diseases (Deadline: 31 May 2022)
- Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery 2.0 (Deadline: 31 May 2022)
- Molecular Mechanisms of Angiogenesis in Health and Diseases (Deadline: 31 May 2022)
- Therapeutic Strategies and Targets for Reactive Oxygen Species Related Diseases (Deadline: 31 May 2022)
- Molecular Mechanisms of Drug-Induced, Immune-Mediated Liver Injury (Deadline: 31 May 2022)
- Human and Animal Monocytes and Macrophages in Homeostasis and Disease 3.0 (Deadline: 31 May 2022)
- Metabolic Disturbances in Hematologic Malignancies (Deadline: 31 May 2022)
- Molecular Advances in Skin Diseases (Deadline: 31 May 2022)
- New Applications in the Diagnosis and Therapy of Diseases (Deadline: 31 May 2022)
- The Role of Oxidative Stress and Epithelium-Derived Cytokines in Atopic Dermatitis (Deadline: 31 May 2022)
- The Role of Extracellular Matrix in Human Health and Disease (Deadline: 31 May 2022)
- New Insights into Psoriasis (Deadline: 31 May 2022)
- RNA Modifications in Disease and Development (Deadline: 31 May 2022)
- Sarcomere Function in Health and Disease (Deadline: 31 May 2022)
- Thyroid Hormones and NAFLD: New Insights 2.0 (Deadline: 31 May 2022)
- Angiogenesis and Lymphangiogenesis in Cancer (Deadline: 31 May 2022)
- MicroRNAs and Stem Cells 3.0 (Deadline: 31 May 2022)
- Molecular Advances in Alzheimer's Disease (Deadline: 31 May 2022)
- Cardiac Repair and Regeneration: New Molecular Mechanisms and Therapeutics 2.0 (Deadline: 31 May 2022)
- Purinergic Signaling in Neuroinflammation 2.0 (Deadline: 31 May 2022)
- Mechanisms of Cancer Development in Diabetes (Deadline: 31 May 2022)
- Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 2.0 (Deadline: 31 May 2022)
- Embracing the Diversity of Perinatal Brain Injury: Molecular Mechanisms and Novel Therapeutics (Deadline: 15 June 2022)
- Gene Expression and Molecular Targets of Oral Cancer and Periodontal Diseases (Deadline: 15 June 2022)
- Scientific Discoveries Supporting Theories in Science: From Thinking to Practice (Deadline: 15 June 2022)
- Cellular and Molecular Mechanisms in Oxidative Stress-Related Diseases (Deadline: 20 June 2022)
- Molecular Research on Emerging Mosquito-Transmitted RNA Viruses 3.0 (Deadline: 29 June 2022)
- Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases (Deadline: 29 June 2022)
- Molecular and Cellular Mechanisms of Brain Disease: Hippocampus as a Nodal Point (Deadline: 30 June 2022)
- Transcription in Cancer Initiation and Progression (Deadline: 30 June 2022)
- Filaggrin (Deadline: 30 June 2022)
- Current Mechanistic Understandings of Lymphedema and Lipedema (Deadline: 30 June 2022)
- New Pharmacological Approaches for Rare Diseases (Deadline: 30 June 2022)
- Telomeres and Human Disease (Deadline: 30 June 2022)
- Host Microbiota and Cancer: From Pathogenic Mechanisms to Therapy (Deadline: 30 June 2022)
- Regulation of Trace Metals in Neurodegenerative and Neurodevelopmental Disorders (Deadline: 30 June 2022)
- Dual Targeting as a Strategy to Counteract Chronic Diseases (Deadline: 30 June 2022)
- Advanced Research on Neurological Disorders: From Novel Molecular Mechanism to Innovative Therapeutic Paradigm (Deadline: 30 June 2022)
- Molecular Advances in Breast Cancer (Deadline: 30 June 2022)
- Pro-inflammatory Nutrients: Focus on Gliadin and Celiac Disease 2.0 (Deadline: 30 June 2022)
- Molecular Advances in Lung Diseases (Deadline: 30 June 2022)
- Neuropilins and VEGFR-Interacting Proteins in Health and Disease (Deadline: 30 June 2022)
- Bladder Cancer 2.0 (Deadline: 30 June 2022)
- Hematopoietic Stem Cells and Disease Treatment (Deadline: 30 June 2022)
- Cellular and Molecular Research of Kidney Diseases (Deadline: 30 June 2022)
- Retinal Pigment Epithelium: Molecular Mechanisms of Homeostasis and Function (Deadline: 30 June 2022)
- Atherosclerotic and Cardiometabolic Disease: From Molecular Basis to Therapeutic Advances (Deadline: 30 June 2022)
- Advances in Molecular Research on Prostate Cancer (Deadline: 30 June 2022)
- New Strategies Protecting from Ischemia/Reperfusion (Deadline: 30 June 2022)
- mTOR Signaling Network in Cell Biology and Human Disease (Deadline: 30 June 2022)
- Molecular Research in Uterine Biology and Pathophysiology (Deadline: 30 June 2022)
- Fatty Acids and Inflammation: From Biochemistry to Human Evidence (Deadline: 30 June 2022)
- Impact of Dyslipidemia and Metabolic Syndrome on Cardiac Dysfunction (Deadline: 30 June 2022)
- Molecular Advances in SARS-CoV-2 Transmission, Infection and Pathology (Deadline: 30 June 2022)
- Role of G-Protein Coupled Receptors in Cardiovascular Diseases (Deadline: 30 June 2022)
- Molecular Research in Antidepressant Response (Deadline: 30 June 2022)
- Molecular Mechanisms and Pathophysiology of Head and Neck Diseases (Deadline: 30 June 2022)
- Immunotherapies for Cancer (Deadline: 30 June 2022)
- In Vitro Models of Tissue and Organ Regeneration (Deadline: 30 June 2022)
- Biology and Pathology of the Human Hair Follicle (Deadline: 30 June 2022)
- Osteoporosis: From Molecular Mechanisms to Therapies 3.0 (Deadline: 30 June 2022)
- Mechanisms of Therapeutic Peptides (Deadline: 30 June 2022)
- Integrin Signaling and Human Pathologies 2021 (Deadline: 30 June 2022)
- Molecular Advances in Thrombotic Microangiopathy and Thrombotic Complications (Deadline: 30 June 2022)
- The Role of Reactive Oxygen Species (ROS) in the Immune System and Health (Deadline: 30 June 2022)
- Prostate Cancer: Stroma Implication in Progression, Diagnosis and Prognosis (Deadline: 30 June 2022)
- Recent Advances of Biochemistry and Molecular Biology of Infectious Diseases (Deadline: 30 June 2022)
- Nutrient Metabolites and Their Receptors in Human Diseases (Deadline: 30 June 2022)
- RNA-Binding Proteins and Their Emerging Roles in Cancer 2.0 (Deadline: 30 June 2022)
- Targeted Protein Degradation (Deadline: 30 June 2022)
- Molecular Mechanisms of Multiple Sclerosis Pathology (Deadline: 30 June 2022)
- Lipid and Atherosclerosis (Deadline: 30 June 2022)
- Focus on Wound Healing (Deadline: 30 June 2022)
- Molecular Studies of Glioblastoma (Deadline: 30 June 2022)
- Renin-Angiotensin-Aldosterone System in Pathologies (Deadline: 30 June 2022)
- Glaucoma: From Pathophysiology to Novel Therapies (Deadline: 30 June 2022)
- Smart Biomaterials in Tissue Regeneration (Deadline: 30 June 2022)
- Molecular Imaging in Precision Medicine: A Challenging Alliance (Deadline: 30 June 2022)
- Inflammatory Bowel Diseases: Pathogenesis and Future Developments (Deadline: 30 June 2022)
- Mechanisms of Lung Vascular Remodeling in Acute and Chronic Lung Diseases (Deadline: 30 June 2022)
- Coronavirus Disease (COVID-19): Pathophysiology 2.0 (Deadline: 30 June 2022)
- Extracellular Vesicles and Metastatic Niche 3.0 (Deadline: 1 July 2022)
- Extracellular Matrix in Development and Disease 3.0 (Deadline: 15 July 2022)
- Congenital and Acquired Platelet Disease 2.0 (Deadline: 15 July 2022)
- The Role of MSCs on Inflammatory and Fibrotic Diseases (Deadline: 15 July 2022)
- Molecular Mechanisms and Biomarkers in Drug-Associated Organ Injury (Deadline: 15 July 2022)
- Changes in Retinal Disease in Association with Choroid (Deadline: 15 July 2022)
- Unraveling the Molecular Pathways of Alzheimer's Disease (Deadline: 20 July 2022)
- Advances in Molecular and Translational Medicine (Deadline: 29 July 2022)
- Molecular Advances in Colorectal Cancer (Deadline: 30 July 2022)
- Molecular Advances in MAFLD (Deadline: 30 July 2022)
- The Role of Fibrinolytic System in Health and Disease 2.0 (Deadline: 31 July 2022)
- New Perspectives in Molecular Diagnosis of Neuromuscular Disorders (Deadline: 31 July 2022)
- Frontiers in Anti-aging Treatment Development (Deadline: 31 July 2022)
- Compounds with Anxiolytic or Antidepressant Properties (Deadline: 31 July 2022)
- Recent Advances in Salivary Gland and Their Function 2.0 (Deadline: 31 July 2022)
- New Paradigms in Aldosterone and Mineralocorticoid Receptor Pathophysiology (Deadline: 31 July 2022)
- Biogenesis and Functional Roles of Lysosomes: Their Implications for the Pathogenesis and Therapy of Human Diseases 2.0 (Deadline: 31 July 2022)
- Frontier Research on Retina (Deadline: 31 July 2022)
- Molecular Research in Renal Tumors (Deadline: 31 July 2022)
- Advanced Research on Reproductive System Disease 2022 (Deadline: 31 July 2022)
- The Molecular Basis of Complications and Pitfalls in Radiotherapy and Potent Methods for Compromise (Deadline: 31 July 2022)
- Molecular Biology of Hereditary Tumors (Deadline: 31 July 2022)
- Role and Application of Stem Cells in Regenerative Medicine 3.0 (Deadline: 31 July 2022)
- Role of Non-coding RNAs and Untranslated RNA Regions in Disease (Deadline: 31 July 2022)
- Osteoblast Differentiation and Activity in Skeletal Diseases 2.0 (Deadline: 31 July 2022)
- Mitochondrial Dysfunction: A Common Trigger in Neurodegenerative and Metabolic Non-communicable Diseases (Deadline: 31 July 2022)
- Molecular Research in Radiobiology 2.0 (Deadline: 31 July 2022)
- Osteosarcoma: Molecular Alterations, Heredity, and Metabolism (Deadline: 31 July 2022)
- Zebrafish as a Model in Human Disease (Deadline: 31 July 2022)
- Neuroinfectiology: Molecular and Cellular Mechanisms of Neurotropic Virus Infection 3.0 (Deadline: 31 July 2022)
- Cell Programming for Cardiovascular Disease Modeling and Therapy 2.0 (Deadline: 31 July 2022)
- Advanced Models of Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Organ-on-a-Chips (Deadline: 31 July 2022)
- DNA Replication Stress and Chromosomal Instability 2.0 (Deadline: 31 July 2022)
- Mechanisms of Adiponectin Action 3.0 (Deadline: 31 July 2022)
- Apolipoproteins in Health and Disease (Deadline: 31 July 2022)
- Sepsis: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 July 2022)
- Advanced Research in Cardiopulmonary Injury (Deadline: 31 July 2022)
- New Insights in Cardiac Ischemic Diseases (Deadline: 31 July 2022)
- Role of ncRNAs Classes as Biomarkers for Diagnostic and Prognosis in Cancer 2021 (Deadline: 31 July 2022)
- New Insight and Perspectives in Non-melanoma Skin Cancer: From Histopathological Diagnostics to Molecular Biology (Deadline: 31 July 2022)
- Novel Insights in Retinal Diseases Pathophysiology and Therapies (Deadline: 31 July 2022)
- Physiological and Pathological Aspects of Unfolded Protein Response 2.0 (Deadline: 31 July 2022)
- Infections, Inflammation and Neurodegeneration in Alzheimer’s Disease 2.0 (Deadline: 31 July 2022)
- Molecular Regulations in Neural Central Development and Morphogenesis (Deadline: 31 July 2022)
- Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 3.0 (Deadline: 31 July 2022)
- New Insight into Nutrient Response and Adaptation: From Molecular Mechanism to Metabolic Reprogramming (Deadline: 31 July 2022)
- Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0 (Deadline: 31 July 2022)
- Molecular Insights and Multi-Omics in Sleep Disorders (Deadline: 31 July 2022)
- Therapeutic Potential of Targeting Connexins in Managing Disease Onset and Progression 2.0 (Deadline: 31 July 2022)
- Exosomes in Cancer Diagnosis and Therapy 2.0 (Deadline: 31 July 2022)
- Collagen VI-Related Myopathies—COL6-RMs (Deadline: 31 July 2022)
- The Role of Autophagy Processes in Human Diseases (Deadline: 31 July 2022)
- Regulatory Mechanisms of Ion Channels and Their Potential as Therapeutic Targets (Deadline: 31 July 2022)
- Molecular Pathophysiology of Chronic Lung Disease (Deadline: 31 July 2022)
- Pathological Mechanisms Involved in Restenosis Progression (Deadline: 31 July 2022)
- Advances in the Pathogenesis and Treatment of Hypertension (Deadline: 31 July 2022)
- Musculoskeletal Metabolism and Inflammation (Deadline: 31 July 2022)
- Mucopolysaccharidoses: Diagnosis, Treatment, and Management 3.0 (Deadline: 31 July 2022)
- Lipid and Metabolic Syndrome (Deadline: 31 July 2022)
- Emerging Viruses: Molecular Mechanisms of Native and Artificial Immune Response (Deadline: 31 July 2022)
- New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases (Deadline: 31 July 2022)
- Molecular Research of Vascular Aspects in Pregnancy (Deadline: 31 July 2022)
- New Insights into Adipose Tissue Metabolic Function and Dysfunction (Deadline: 31 July 2022)
- Molecular Targeted Therapeutic Strategies for Glioblastoma (Deadline: 31 July 2022)
- Zebrafish as an Experimental Model for Human Disease (Deadline: 31 July 2022)
- Protease-Protease Inhibitors in the Retinal Disease (Deadline: 31 July 2022)
- Molecular Research in Oral Diseases (Deadline: 31 July 2022)
- Diabetic Kidney Diseases (Deadline: 31 July 2022)
- Recent Approaches for Wound Treatment (Deadline: 31 July 2022)
- Ion Channels in Sperm Physiology 2.0 (Deadline: 31 July 2022)
- Molecular Research in Atherosclerosis (Deadline: 31 July 2022)
- Whole Joint Philosophy for the Treatment of Early Osteoarthritis: Cellular and Molecular Perspectives (Deadline: 31 July 2022)
- The Role of MicroRNAs, tRNA Fragments, and Circular RNAs in Leukemia (Deadline: 31 July 2022)
- The Role of the Circadian Clock in Cancer and Inflammatory Diseases (Deadline: 31 July 2022)
- Similarities and Differences between Chimeric Antigen Receptor and T Cell Receptor Signaling (Deadline: 1 August 2022)
- Molecular Mechanisms of an Aberrant Specific Immune Response: Role in Pathogenesis of Infectious, Autoimmune Diseases and Cancer (Deadline: 20 August 2022)
- Pathobiology of Acute Kidney Injury 2.0 (Deadline: 20 August 2022)
- Molecular Research of Hematological Changes in Cardiovascular Diseases (Deadline: 28 August 2022)
- Mitochondrial Dysfunction: A Metabolic, Cardiovascular, Neurodegenerative and Neuromuscular Issue (Deadline: 30 August 2022)
- Recent Advances in Glycoproteomics: Theory, Methods and Applications (Deadline: 30 August 2022)
- Thromboinflammation: An Evolving Multifaceted Concept (Deadline: 30 August 2022)
- Molecular Research on Cardiomyopathy 2.0 (Deadline: 30 August 2022)
- Neuroblastoma Molecular Biology and Therapeutics 2.0 (Deadline: 30 August 2022)
- The Physiology and Pathophysiology of the Erythrocyte (Deadline: 31 August 2022)
- Antimicrobial Peptides and Antimicrobial Chemokines 2.0 (Deadline: 31 August 2022)
- DNA Damage, Oxidative Stress and Human Disease (Deadline: 31 August 2022)
- Multiple Myeloma Bone Disease: Symptoms, Diagnosis and Treatment 2.0 (Deadline: 31 August 2022)
- Molecular Mechanisms in Simultaneous Development of Lower Urinary Tract Symptoms and Erectile Dysfunction (Deadline: 31 August 2022)
- Gene and Cell Therapy for Ophthalmology Disease (Deadline: 31 August 2022)
- Tumor Metabolism and Immune Evasion (Deadline: 31 August 2022)
- Cancer Immunotherapies and NK/CIK/CAR-T (Deadline: 31 August 2022)
- Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities (Deadline: 31 August 2022)
- Cystic Fibrosis and CFTR Interactions (Deadline: 31 August 2022)
- Molecular Biology of Age-Related Macular Degeneration (AMD) 3.0 (Deadline: 31 August 2022)
- Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation 2.0 (Deadline: 31 August 2022)
- Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials (Deadline: 31 August 2022)
- Molecular Research and Treatment of Skin Diseases 2.0 (Deadline: 31 August 2022)
- Chronic Myeloid Leukemia: From Molecular Mechanisms to Targeted Therapies (Deadline: 31 August 2022)
- Transglutaminase Diseases, from the Experimental Laboratory to Human Pathology Applications 2.0 (Deadline: 31 August 2022)
- Metabolic Regulators of Psychological Stress and Brain Trauma (Deadline: 31 August 2022)
- Cytokines: From Cancer to Autoimmunity (Deadline: 31 August 2022)
- Recent Advances in Acute Myeloid Leukemia in Children (Deadline: 31 August 2022)
- Targeted Biomarkers for Combinatorial Therapies in Neuroinflammation and Brain Tumors (Deadline: 31 August 2022)
- Adipokines, Myokines and Physical Exercise in Health and Disease (Deadline: 31 August 2022)
- Research Progress of Platelet Metabolism in Regulating Platelet Function and Thrombosis (Deadline: 31 August 2022)
- State-of-the-Art Molecular Mechanisms of Hematopathology in Korea (Deadline: 31 August 2022)
- Recent Advances in Intermediate Filaments 2.0 (Deadline: 31 August 2022)
- Immunological Approaches in Tumor Therapy (Deadline: 31 August 2022)
- The Crosstalk between Adipose Tissue and Cancer (Deadline: 31 August 2022)
- Melanosome Transport/Transfer and Melanin Pigmentation in the Skin 2.0 (Deadline: 31 August 2022)
- Molecular Links between Periodontitis and Systemic Diseases 2.0 (Deadline: 31 August 2022)
- Study of Endoplasmic Reticulum Stress and Unfolded Protein Response (Deadline: 31 August 2022)
- New Frontiers in Musculoskeletal Tissue Repair and Tissue Regeneration (Deadline: 31 August 2022)
- Nuclear Receptors in Health and Diseases (Deadline: 31 August 2022)
- From Pathogenesis to Treatment—New Perspectives in Rheumatology (Deadline: 31 August 2022)
- Mechanisms of Inflammation in Degenerative Cardiovascular Conditions 3.0 (Deadline: 31 August 2022)
- Non-coding RNAs and Novel Therapeutic Targets in Human Cancers and Ageing-Related Diseases (Deadline: 31 August 2022)
- Frontiers on Induced Pluripotent Stem Cells (iPSCs) (Deadline: 31 August 2022)
- MicroRNA-Based Cancer Therapy 2022 (Deadline: 31 August 2022)
- Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping (Deadline: 31 August 2022)
- Novel Insights into Cancer Drug Resistance: From Molecular Basis to Emerging Therapeutic Strategies (Deadline: 31 August 2022)
- Abnormal Regulation of Cellular Actions of Cardiovascular Factors (Deadline: 31 August 2022)
- Redox Balance and Materials Used in the Treatment of Craniofacial Diseases (Deadline: 31 August 2022)
- The Tumor Microenvironment and Immune System in Biliopancreatic Cancers (Deadline: 31 August 2022)
- Innovation through Tradition: The Current Challenges in Cancer Treatment 2.0 (Deadline: 31 August 2022)
- Current Trends of Natural Bioactive Molecules in Regulation of Cell Signaling Pathways in Different Diseases (Deadline: 31 August 2022)
- Ion Channels and Transporters: The New Targets for Cancer (Deadline: 31 August 2022)
- Molecular Research on Rett Syndrome and Related Disorders: From the Past towards the Future 2.0 (Deadline: 31 August 2022)
- Molecular Research on Cancer Stem Cell (Deadline: 31 August 2022)
- Molecular Pathogenesis and Therapeutics in Urothelial Carcinoma (Deadline: 31 August 2022)
- Pathophysiology and Treatment of Inflammatory Bowel Disease (Deadline: 31 August 2022)
- Therapeutic Aspects of Gasotransmitters in Cardiovascular and Renal Disease 2.0 (Deadline: 31 August 2022)
- New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0 (Deadline: 31 August 2022)
- Molecular Mechanisms and Extracerebral Factors Affecting Brain Injury (Deadline: 31 August 2022)
- Common Molecular Mechanisms in Embryonic Development (Deadline: 31 August 2022)
- Therapeutic Potentials of Natural Products on Cerebrovascular Diseases and Neurodegeneration (Deadline: 31 August 2022)
- Photodynamic Therapy and Photodetection (Deadline: 1 September 2022)
- Sleep Apnea and Intermittent Hypoxia 3.0 (Deadline: 15 September 2022)
- Recent Advances in the Inverse Relationship of Cancer and Alzheimer’s Disease (Deadline: 17 September 2022)
- Molecular Pathogenesis and Treatment in Neurodegeneration: Current Evidence and Future Directions (Deadline: 20 September 2022)
- Transgenic Mice in Human Diseases: Insights from Molecular Research 3.0 (Deadline: 20 September 2022)
- Fate of Pancreatic Islets in Type 2 Diabetes (Deadline: 25 September 2022)
- Molecular Markers and Targets in Acute Myeloid Leukemia (Deadline: 30 September 2022)
- Protein Kinase in Disease (Deadline: 30 September 2022)
- Liver Damage and Repair 2.0 (Deadline: 30 September 2022)
- Towards Precision Prognostication and Personalized Therapeutics through Proteomics (Deadline: 30 September 2022)
- Molecular Mechanisms of Ischemia-Induced Renal Fibrosis (Deadline: 30 September 2022)
- Targeted Therapies and Molecular Methods in Cancer (Deadline: 30 September 2022)
- Non-coding RNAs in Tumor Development and Angiogenesis (Deadline: 30 September 2022)
- Role of Drosophila in Human Disease Research 3.0 (Deadline: 30 September 2022)
- The Emerging Role of Non-ionizing Radiation in Biomedical Applications (Deadline: 30 September 2022)
- Zebrafish as an Experimental Model for Metabolic Disease: From Morphology to Therapy the Key Role of Translational Research in Biomedicine (Deadline: 30 September 2022)
- Advanced Research in Regenerative Ophthalmology (Deadline: 30 September 2022)
- Muscle Atrophy: From Bench to Bedside (Deadline: 30 September 2022)
- Advances in Molecular Research and Novel Diagnostic Technics of Hematological Malignancies (Deadline: 30 September 2022)
- The Microbiota–Gut–Brain Axis in Behaviour and Brain Disorders (Deadline: 30 September 2022)
- Genetic and Molecular Mechanisms of Liver Disease (Deadline: 30 September 2022)
- Role of Telomeres and Telomerase in Cancer and Aging 2022 (Deadline: 30 September 2022)
- Molecular Diagnosis and Treatment of Skin Cancers (Deadline: 30 September 2022)
- BMP Signaling and TGF-β Family in Cancer Development (Deadline: 30 September 2022)
- Molecular Mechanisms of Cardiovascular Disease 2022 (Deadline: 30 September 2022)
- Advances in Ischemic Retinopathies (Deadline: 30 September 2022)
- The Emerging Role of Kinase Inhibitors in Cancer (Deadline: 30 September 2022)
- 2nd Edition: Molecular Mechanisms Regulating Osteoclastogenesis (Deadline: 30 September 2022)
- Molecular Advances in Aldosterone and Aldosterone Related Disorders (Deadline: 30 September 2022)
- Homeostasis: Metals and Cellular Redox and Immunity Status (Deadline: 30 September 2022)
- New Advance in Corneal Dystrophies (Deadline: 30 September 2022)
- Molecular and Cellular Factors Regulating Signal Transduction, Diseases, and Stem Cells (Deadline: 30 September 2022)
- Tumor Microenvironment and Its Actors: Are Ion Channels Relevant? (Deadline: 30 September 2022)
- Emerging Concepts and Novel Therapeutics to Overcome Treatment Resistance in Prostate Cancer (Deadline: 30 September 2022)
- Review of Cardiac Fibrosis: Recent Advances and Future Directions 2022 (Deadline: 30 September 2022)
- Genome Editing Therapy Using Viral Vectors of Adenovirus and Lentivirus (Deadline: 30 September 2022)
- HPV Elimination: A Highway to the Elimination of HPV-Associated Cancers (Deadline: 30 September 2022)
- Molecular Pathology, Diagnostics, and Therapeutics of Nephropathy 2.0 (Deadline: 30 September 2022)
- Molecular Mechanisms of Periodontal Disease 3.0 (Deadline: 30 September 2022)
- Advance in Reproductive Biology and Related Diseases (Deadline: 30 September 2022)
- The Role of Ion-Transporting Proteins in Human Disease (Deadline: 30 September 2022)
- Novel Molecular Approaches to Skeletal Muscle Disease and Disuse 2.0 (Deadline: 30 September 2022)
- Gene Transfer in Microorganisms and Human Diseases (Deadline: 30 September 2022)
- Mesothelial Cell: Its Repair, Plasticity, and Relationship with Tumor Dissemination (Deadline: 30 September 2022)
- Ovarian Disorders: From Molecular Basis to Therapeutic Advances (Deadline: 30 September 2022)
- The Role of G Protein-Coupled Receptor in Human Disease (Deadline: 30 September 2022)
- Targeting Mitochondria in Aging and Disease 2.0 (Deadline: 30 September 2022)
- Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment (Deadline: 30 September 2022)
- Emerging Molecular Mechanisms for the Diagnosis and Treatment of Fragile X Syndrome (Deadline: 30 September 2022)
- Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 3.0 (Deadline: 30 September 2022)
- Mechanisms of Cardiovascular Disease: Molecular Perspective 2.0 (Deadline: 30 September 2022)
- Protein Folding Diseases—Molecular Mechanisms and Therapeutic Approaches (Deadline: 30 September 2022)
- Non-coding RNAs in Cancer, Aging and Regeneration (Deadline: 30 September 2022)
- Extracellular Vesicles in Microbes, Pathogens and Infectious Diseases (Deadline: 30 September 2022)
- Stroke: Merging Neuroprotection and Neuroregeneration towards Therapeutics 2.0 (Deadline: 30 September 2022)
- Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies 2.0 (Deadline: 30 September 2022)
- Mitochondria: Aging, Metabolic Syndrome and Cardiovascular Diseases (Deadline: 30 September 2022)
- Gut and the Liver in Health and Disease (Deadline: 30 September 2022)
- Neural Stem Cells: Focusing on Disease Modeling and Translational Application (Deadline: 30 September 2022)
- Molecular Mechanism and Application of Somatic Cell Cloning in Mammals (Deadline: 30 September 2022)
- The Kinase Inhibitors in Human Diseases (Deadline: 30 September 2022)
- Endocannabinoids, Cannabinoids and Psychiatry: Biological Mechanisms 2.0 (Deadline: 30 September 2022)
- Pluripotent Stem Cells and Organoids on Disease Modeling and Therapeutic Potentials (Deadline: 30 September 2022)
- Matricellular Proteins in Human Diseases (Deadline: 30 September 2022)
- Arteriogenesis, Angiogenesis and Vascular Remodeling (Deadline: 1 October 2022)
- Cell Death in Acute Organ Injury and Fibrosis (Deadline: 10 October 2022)
- GPR37 and Related Receptors: Disease Regulation (Deadline: 15 October 2022)
- Aging and Heart Disease (Deadline: 15 October 2022)
- Pathophysiologic Mechanisms of Eye Diseases and Novel Therapeutic Approaches (Deadline: 15 October 2022)
- Bone and Soft Tissue Sarcomas - Basic Research and Multimodal Treatment Concepts (Deadline: 20 October 2022)
- The Role and Characterization of Neutrophils in Human Diseases (Deadline: 20 October 2022)
- Skeletal Muscle and Metabolic Disorders (Deadline: 25 October 2022)
- Molecular Features of Skin Cancer (Deadline: 27 October 2022)
- Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy 2.0 (Deadline: 30 October 2022)
- Vasculitis (Deadline: 30 October 2022)
- Biomarkers in Rare Diseases 3.0 (Deadline: 30 October 2022)
- Regenerative Medicine Protocols: From Molecular Research to Application (Deadline: 30 October 2022)
- Autoimmunity and COVID-19 (Deadline: 30 October 2022)
- Molecular Imaging in Diabetes, Obesity, and Infections 3.0 (Deadline: 30 October 2022)
- Contribution of Dysfunctional Microvasculature to Cardiovascular Diseases (Deadline: 30 October 2022)
- Application of Advanced Molecular Methods to Study Infections (Deadline: 30 October 2022)
- New Insights into Glioblastoma: Cellular and Molecular (Deadline: 31 October 2022)
- Recent Research in Primary Osteoporosis: From a Bone Marrow Adiposity Perspective (Deadline: 31 October 2022)
- Molecular Pathological Mechanisms of Skin Cancer (Deadline: 31 October 2022)
- Strategies to Counteract Oxidative Stress and Inflammation in Chronic-Degenerative Diseases 2.0 (Deadline: 31 October 2022)
- CAR-T Cell Therapy 2.0 (Deadline: 31 October 2022)
- Wound Repair and Regeneration 2022 (Deadline: 31 October 2022)
- New Therapeutic Tools in Diabetic Retinopathy (Deadline: 31 October 2022)
- Hearing Loss: Molecular Mechanisms, Treatment and Prevention (Deadline: 31 October 2022)
- Molecular and Cellular Mechanisms of Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases (Deadline: 31 October 2022)
- Leptin and Relatives: Molecules at the Crossroad of Inflammation and Immunometabolism 2.0 (Deadline: 31 October 2022)
- Molecular Research of Cerebrovascular and Neurological Disorders: Role of Oxidative Stress and Pro-inflammatory Stimuli, Volume II (Deadline: 31 October 2022)
- Neurodegeneration 2022: From Genetics to Molecules (Deadline: 31 October 2022)
- Blood-Brain Barrier in CNS Injury and Repair 2022 (Deadline: 31 October 2022)
- Blood Immune and Circulating Tumor Cells (Deadline: 31 October 2022)
- Advances in the Comprehension of the Molecular Basis of Cancer and New Therapeutic Strategies 2021 (Deadline: 31 October 2022)
- Pathological and Molecular Markers for Diagnosis, Prognostic and Therapeutics of Prostate Cancers (Deadline: 31 October 2022)
- Advances of Chromatin in Human Diseases (Deadline: 31 October 2022)
- Molecular Mechanisms Associated with Drug Addiction Vulnerability (Deadline: 31 October 2022)
- Retinal Neurodegenerative Diseases: Molecular Targets Driving Neuroinflammation and Neuroprotection 2022 (Deadline: 31 October 2022)
- Barrier Function of Skin and Oral Mucosa 2.0 (Deadline: 31 October 2022)
- Molecular Mechanisms Underlying Chronic and Degenerative Diseases (Deadline: 31 October 2022)
- Molecular Research of Autophagy and Apoptosis 2022 (Deadline: 31 October 2022)
- Pediatric Lung Diseases: Novel Molecular Insights and Therapeutic Advances (Deadline: 31 October 2022)
- Advances in Metabolism, Immunology, Genetics in Thyroid Cancer and Thyroid Disease: From Bench to Therapy (Deadline: 31 October 2022)
- Molecular Research on Platelet Activity in Health and Disease 2022 (Deadline: 31 October 2022)
- Cross-Talk between Obesity and Eye Diseases: Pathogenesis and Preventive/Therapeutic Strategies (Deadline: 31 October 2022)
- Role of Interleukins in Cutaneous Diseases and Novel Therapeutic Approaches (Deadline: 31 October 2022)
- Melanoma Tissue Structure, Cell Composition, Interactions and Metabolism: From Cancer Pathology to Therapeutic Strategies (Deadline: 31 October 2022)
- Diabetes and Dementia (Deadline: 31 October 2022)
- Sustainable Approaches in Skin Conditions (Deadline: 31 October 2022)
- Highlights in Pathophysiology of the Musculoskeletal System (Deadline: 31 October 2022)
- Looking into the Skin in Health and Disease: From Microscopy Imaging Techniques to Molecular Analysis (Deadline: 31 October 2022)
- The Role of microRNA in Human Diseases (Deadline: 31 October 2022)
- Updates & New Concepts in Collagen (Deadline: 31 October 2022)
- Pathogenesis of Pregnancy-Related Complication (Deadline: 31 October 2022)
- Tumor Microenvironment from a Precision Medicine Perspective 2.0 (Deadline: 31 October 2022)
- Male Fertility: New Horizons for Investigating Reproductive System Diseases (Deadline: 31 October 2022)
- Molecular Research on Pancreatic Cancer: From Pathology to Therapy (Deadline: 31 October 2022)
- Advances in the Molecular of Lung Disease (Deadline: 31 October 2022)
- Molecular Mechanisms of Renal Diseases (Deadline: 31 October 2022)
- Revolving from Hypertension to Cardiovascular Disease (Deadline: 31 October 2022)
- Targeted Nanoparticles and Specific Cell Targeting Strategies for Chronic Liver Disease (Deadline: 31 October 2022)
- New Molecular and Mechanistic Basis for the Inflammasome Manipulation in Cancer and Disease (Deadline: 31 October 2022)
- Targeted Treatments in Cancer (Deadline: 31 October 2022)
- Aging and Senescence 3.0 (Deadline: 31 October 2022)
- Molecular Mechanisms of Endocrine-Disrupting Chemicals (EDC) Action in the Pathogenesis of Human Diseases (Deadline: 31 October 2022)
- The Gas6/TAM System at the Crossroads of Inflammation and Fibrosis (Deadline: 31 October 2022)
- Mitochondrial Respiration in Physiology and Pathology (Deadline: 31 October 2022)
- Advances in Molecular Biology and Targeted Therapy of Leukemias 4.0 (Deadline: 31 October 2022)
- Molecular Mechanisms of Kidney Disease: From Neonates to Adolescents (Deadline: 31 October 2022)
- Retinal Degenerative Diseases (Deadline: 31 October 2022)
- Advanced Molecular Insights into Renal Disorders (Deadline: 31 October 2022)
- Rare Disease Modelling and Its Vital Role in Human Health (Deadline: 31 October 2022)
- Cardiac Diseases: Molecular Pathology, Diagnostics, and Therapeutics (Deadline: 31 October 2022)
- Advances in Molecular Mechanism of Head and Neck Cancer (Deadline: 31 October 2022)
- miRNAs Mediated Post-transcriptional Regulation in Nervous System (Deadline: 1 November 2022)
- Molecular Research on Acute Lymphoblastic Leukemia 2.0 (Deadline: 10 November 2022)
- Hidradenitis Suppurativa and Related Disorders (Deadline: 15 November 2022)
- Purinergic Signalling in Physiology and Pathophysiology (Deadline: 15 November 2022)
- Photodynamic Therapy: Outlook and Future Direction (Deadline: 15 November 2022)
- New Advances in Hepatitis Virus Infection (Deadline: 15 November 2022)
- Genomic Variation of SARS-CoV-2 (Deadline: 15 November 2022)
- The Role of Ceramide Kinase in Cancer, Neurodegeneration, and Inflammation (Deadline: 15 November 2022)
- Advances in Molecular Studies of Solid Tumors (Deadline: 15 November 2022)
- Multifaceted and Diversified Roles of MicroRNAs in Health, Diseases and Death (Deadline: 16 November 2022)
- Psychedelic Drugs and Beyond (Deadline: 20 November 2022)
- Spinal Cord Injury: From Mechanisms to Therapeutic Approaches (Deadline: 28 November 2022)
- Advances in the Pharmacological Treatment of Dementia (Deadline: 30 November 2022)
- Molecular Decision Making in the Treatment of Colorectal Liver Metastases (Deadline: 30 November 2022)
- Oxidative Stress and Brain Injury 3.0 (Deadline: 30 November 2022)
- Recent Advances in Skin Disease and Comorbidities (Deadline: 30 November 2022)
- Molecular Advances in Infectious Disease (Deadline: 30 November 2022)
- RNA Metabolism: Role in Human Pathophysiology and Its Potential for Therapeutic Interventions (Deadline: 30 November 2022)
- Advances in Stem Cell Research for Future Therapies and In Vitro Disease Modelling 2.0 (Deadline: 30 November 2022)
- Molecular Mechanisms and Therapeutics of Parkinson's Disease 2022 (Deadline: 30 November 2022)
- The Structural-Functional Rationale for Targeting the Tumor Microenvironment (Deadline: 30 November 2022)
- Understanding Parkinson's Disease (Deadline: 30 November 2022)
- Tissue-Specific Direct and Indirect Effects of Metformin and Its Application 2.0 (Deadline: 30 November 2022)
- TGF-β Signaling in Human Disease (Deadline: 30 November 2022)
- Molecular Mechanisms of Respiratory Diseases (Deadline: 30 November 2022)
- Natural Bioactive Compounds to Promote Cardiovascular Health (Deadline: 30 November 2022)
- Epigenetic Mechanisms and Human Pathology 3.0 (Deadline: 30 November 2022)
- Transcription Factors in Lung Cancer: Mechanisms and Future Perspectives (Deadline: 30 November 2022)
- Cardiovascular Endocrinology Research 2022 (Deadline: 30 November 2022)
- Molecular Sciences in Non-Ischemic Cardiomyopathy (Deadline: 30 November 2022)
- Sympathetic Nerves and Cardiovascular Diseases (Deadline: 30 November 2022)
- Advances in Research on Pulmonary Hypertension 2.0 (Deadline: 30 November 2022)
- Impact of Molecular Biology in the Prevention, Diagnosis and Treatment of Invasive Meningococcal Disease (Deadline: 30 November 2022)
- Transcriptomics in Health and Disease (Deadline: 30 November 2022)
- Advanced Research on Wound Healing (Deadline: 30 November 2022)
- Molecular Research on Platelet Function in Disease 2.0 (Deadline: 30 November 2022)
- Molecular Regulators of Cardiovascular Disease (Deadline: 10 December 2022)
- Rare Diseases—Molecular Mechanisms and Therapeutic Strategies (IV) (Deadline: 30 December 2022)
- Advances in Cardiac Regenerative Medicine (Deadline: 31 December 2022)
- Advances in Antimicrobial Nanoparticles 2022 (Deadline: 31 December 2022)
- Recent Molecular Advances on Diabetic Retinopathy (Deadline: 31 December 2022)
- Molecular Studies in Aging: New Frontiers (Deadline: 31 December 2022)
- MicroRNAs in Periodontal Disease and Systemic Diseases (Deadline: 31 December 2022)
- Soft Tissue Mineralization: Mechanisms, Diseases and Prevention (Deadline: 31 December 2022)
- Connexins Multifaceted Aspects in Homeostasis and Disease (Deadline: 31 December 2022)
- Molecular Advances in Peritoneal Dialysis (Deadline: 31 December 2022)
- Recent Advances of Acute Ischemic Stroke: From the Aspects of Molecular Pathology (Deadline: 31 December 2022)
- Advances in Molecular Science and Genomics: Retinal and Choroidal Diseases (Deadline: 31 December 2022)
- Epigenetic and Transcriptional Control of Skeletal Muscle Homeostasis, Regeneration, and Diseases (Deadline: 31 December 2022)
- Mechanism of Cellular Signaling, Dysfunction and Drug Effects on Liver Diseases (Deadline: 31 December 2022)
- Tetraploid Cells in Health and Disease (Deadline: 31 December 2022)
- Molecular Mechanisms and Treatment of Retinopathy (Deadline: 28 February 2023)
- Lung Diseases: Chronic Respiratory Infections 2.0 (Deadline: 31 March 2023)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Feature Papers in Molecular Pathology, Diagnostics, and Therapeutics
- Immunopathology and Immunosenescence
- Molecular Aspects of Aging
- Molecular Mechanisms of Human Liver Diseases
- Molecular Understanding of the Exocrine Pancreas and Its Disorders
- Programmed Cell Death and Apoptosis
- State-of-the-Art Molecular Mechanisms and Pathophysiology of Bone and Soft Tissue Diseases in Italy
- State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in France
- State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in Italy
- State-of-the-Art Molecular Mechanisms of Hematopathology in France
- State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in Italy
- State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in USA